Increased Plasma Thrombomodulin in Different Subgroups of Patients with Antiphospholipid and Anti β2 Glycoprotein I Antibodies

M E Martinuzzo; R R Forastiero; L O Carreras

doi:10.1055/s-0038-1650404

Thrombosis and Haemostasis, Inhaltsverzeichnis

Thromb Haemost 1996; 75(06): 972-973
DOI: 10.1055/s-0038-1650404

Letter to the Editor

Schattauer GmbH Stuttgart

Increased Plasma Thrombomodulin in Different Subgroups of Patients with Antiphospholipid and Anti β₂ Glycoprotein I Antibodies

M E Martinuzzo

University Institute of Biomedical Sciences, Institute of Cardiology and Cardiovascular Surgery, Favaloro Foundation, Buenos Aires, Argentina

,

R R Forastiero

University Institute of Biomedical Sciences, Institute of Cardiology and Cardiovascular Surgery, Favaloro Foundation, Buenos Aires, Argentina

,

L O Carreras

University Institute of Biomedical Sciences, Institute of Cardiology and Cardiovascular Surgery, Favaloro Foundation, Buenos Aires, Argentina

› Institutsangaben

Abstract

als PDF herunterladen

PDF (188 kb)

Referenzen

References
1 Esmon CT. The roles of protein C and thrombomodulin in the regulation of blood coagulation. J Biol Chem 1989; 264: 4743-4749
2 Ishii H, Majerus PW. Thrombomodulin is present in human plasma and urine. J Clin Invest 1985; 76: 2178-2181
3 Ishii H, Uchiyama H, Kazama M. Soluble thrombomodulin antigen in conditioned medium is increased by damage of endothelial cells. Thromb Haemost 1991; 65: 618-623
4 Boheme MWJ, Nawroth PP, Kling E, Lin J, Amiral J, Riedesel J, Raeth U, Scherbaum WA. Serum thrombomodulin. A novel marker of disease activity in systemic lupus erythematosus. Arthritis Rheum 1994; 4: 572-577
5 Ohdama S, Yoshizawa Y, Kubota T, Aoki N. Plasma thrombomodulin as an indicator of thromboembolic disease in systemic lupus erythematosus. Int J Cardiol 1994; 47 (Suppl. 01) 1-6
6 Triplett DA. Antiphospholipid - protein antibodies: laboratory detection and clinical relevance. Thromb Res 1995; 78: 1-31
7 Martinuzzo ME, Forastiero RR, Carreras LO. Anti β₂ Glycoprotein I antibodies: Detection and association with thrombosis. Br J Haematol 1995; 89: 397-402
8 Takano S, Kimura S, Ohdama S, Aoki N. Plasma thrombomodulin in health and diseases. Blood 1990; 76: 2024-2029
9 Brandt JT, Triplett DA, Alving B, Scharrer I. Criteria for the diagnosis of lupus anticoagulants: an update. Thromb Haemost 1995; 74: 1185-1190
10 Harris EN. The Second International Anticardiolipin Standardization Workshop/The Kingston Antiphospholipid Antibodies (KAPS) Study Group. Am J Clin Pathol 1990; 94: 476-484
11 Yamazaki M, Asakura H, Jokaji H, Saito M, Uotani Ch, Kumabashiri I, Morishita E, Aoshima K, Ikeda T, Matsuda T. Plasma levels of lipoprotein (a) are elevated in patients with the antiphospholipid antibody syndrome. Thromb Haemost 1994; 71: 424-427
12 Karmochkine M, Boffa MC, Piette JC, Cacoub P, Wechsler B, Godeau P, Juhan I, Weiller PJ. Increase in plasma thrombomodulin in lupus erythematosus with antiphospholipid antibodies. Blood 1992; 79: 837-838
13 Carreras LO, Maclouf J. The lupus anticoagulant and eicosanoids. Prostaglandins Leukotrienes and Essential Fatty Acids 1993; 49: 483-488
14 Seigneur M, Dufourcq P, Conri C, Constans J, Mercie P, Pruvost A, Amiral J, Midy D, Baste JC, Boisseau MR. Levels of plasma thrombomodulin are increased in atheromatous arterial disease. Thromb Res 1993; 71: 423-431